Position in BMY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,464,810
-$61,505 QoQ
Shares Held
42,777
+2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#751
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. BMY ranks #5 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,464,810 | 42,777 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,526,315 | 41,654 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,120,165 | 39,306 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,703,607 | 37,774 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $1,836,926 | 39,683 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $2,173,683 | 35,640 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,479,439 | 26,157 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,338,824 | 25,876 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,033,889 | 24,895 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,574,459 | 29,033 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,437,757 | 28,021 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $1,594,184 | 27,467 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,459,914 | 22,829 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,603,972 | 23,142 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,637,222 | 22,755 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,580,543 | 22,233 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,744,666 | 22,658 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,787,628 | 24,478 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,507,186 | 24,173 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,439,783 | 24,333 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,690,946 | 25,306 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,065,992 | 32,726 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,381,331 | 38,390 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,302,776 | 38,195 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,136,792 | 36,340 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $857,838 | 15,390 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||